Active form of the protein kinase CK2 α2β2 holoenzyme is a strong complex with symmetric architecture

Area of Science:

• Biochemistry
• Structural Biology
• Enzymology

Background:

• Casein kinase 2 (CK2) is a vital protein kinase implicated in cell viability and cancer.
• CK2's regulatory mechanisms are distinct from other eukaryotic kinases and incompletely understood.
• Previous structural studies indicated asymmetric holoenzyme arrangements in inactive forms.

Purpose of the Study:

• To elucidate the structural basis of CK2 holoenzyme activity regulation.
• To present high-resolution crystal structures of the active CK2 α2β2 holoenzyme.
• To refine models of CK2 regulation by oligomerization.

Main Methods:

• X-ray crystallography of the monomeric CK2 α2β2 holoenzyme.
• Analysis of holoenzyme architecture and subunit interfaces.
• Biophysical characterization of complex stability in solution.

Main Results:

• Novel crystal structures reveal a symmetric architecture for active CK2 α2β2 tetramers.
• The α/β subunit interfaces form a stable complex, resistant to spontaneous dissociation.
• This contrasts with previously observed asymmetric, inactive trimeric ring structures.

Conclusions:

• The symmetric tetrameric structure represents the active form of the CK2 holoenzyme.
• The inherent stability of the holoenzyme complex is confirmed.
• These findings provide critical insights into CK2's unique regulatory mechanisms.